Prolonged reduction of microglial activation and proliferation in Alzheimer’s disease mice using a selective CSF1R inhibitor prevents cognitive decline, regardless of amyloid plaque pathology. Here, CSF1R is linked to early-onset autosomal dominant Alzheimer disease.